美中嘉和(02453.HK)擬配股總籌2.7億港元 加速腫瘤醫院建設及醫療AI佈局
格隆匯7月22日丨美中嘉和(02453.HK)發佈公吿,2025年7月22日(交易時段前),公司與配售代理(即國泰君安國際)訂立配售協議。據此,配售代理已有條件同意擔任公司獨家配售代理,並以盡最大努力基準促使不少於6名承配人(該等承配人及其最終實益擁有人(如適用)須為獨立第三方)根據配售協議條款按每股配售股份5.54港元的配售價認購4872.36萬股配售股份。
配售事項項下的4872.36萬股配售股份相當於本公吿日期現有已發行H股數目的約18.38%及現有已發行股份數目的約6.63%,以及經配發及發行配售股份擴大後已發行H股數目的約15.52%及已發行股份數目的約6.22%。配售股份將根據一般授權配發及發行。公司將向聯交所申請批准配售股份在聯交所上市及買賣。
待完成後,預期配售事項所得款項總額將約為2.70億港元,而配售事項的所得款項淨額將約為2.59億港元。公司擬將配售事項所得款項淨額按以下方式動用:(a)約7763.4萬港元或30%將用於為上海泰和誠腫瘤醫院的建設提供資金,預期於2026年6月30日前獲悉數動用;(b)約3881.7萬港元或15%將用於為公司及其附屬公司在醫療AI業務方面的資金需求提供支持,包括但不限於日常營運及管理開支、研發開支等,預期於2026年6月30日前獲悉數動用;(c)約6469.5萬港元或25%將用於償付金融機構向公司及其附屬公司提供的貸款,包括但不限於營運資金貸款的本金及利息、固定資產貸款的本金及利息以及融資租賃負債,預期於2026年6月30日前獲悉數動用;及(d)約7763.4萬港元或30%將用於補充公司及其附屬公司的營運資金及一般公司用途,預期於2026年6月30日前獲悉數動用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.